The Valley Desk

ReviewJournal of the American Heart AssociationPublished

Safety and Efficacy of Mavacamten and Aficamten in Patients With Hypertrophic Cardiomyopathy

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Journal of the American Heart Association
Published
Subject terms
Humans; Cardiomyopathy, Hypertrophic; Benzylamines; Uracil; Treatment Outcome; Ventricular Function, Left; Mavacamten; Aficamten; Cardiac Myosin Inhibitors; Symptomatic Hypertrophic Cardiomyopathy
PubMed ID
40055855
PubMed Central ID
PMC12132771
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal